U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
PASCOLIZUMAB
INN   USAN  
USAN   INN  
Official Name English
SB-240683
Preferred Name English
ANTI-IL-4 ANTIBODY
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 4) (HUMAN-MOUSE MONOCLONAL SB-240683 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL SB-240683 .KAPPA.-CHAIN, DIMER
Common Name English
PASCOLIZUMAB [USAN]
Common Name English
Pascolizumab [WHO-DD]
Common Name English
pascolizumab [INN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 4) (HUMAN-MOUSE MONOCLONAL SB-240683 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL SB-240683 .KAPPA.-CHAIN, DIMER
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 20:32:40 GMT 2025 , Edited by admin on Mon Mar 31 20:32:40 GMT 2025
Code System Code Type Description
USAN
NN-39
Created by admin on Mon Mar 31 20:32:40 GMT 2025 , Edited by admin on Mon Mar 31 20:32:40 GMT 2025
PRIMARY
INN
8227
Created by admin on Mon Mar 31 20:32:40 GMT 2025 , Edited by admin on Mon Mar 31 20:32:40 GMT 2025
PRIMARY
SMS_ID
300000021927
Created by admin on Mon Mar 31 20:32:40 GMT 2025 , Edited by admin on Mon Mar 31 20:32:40 GMT 2025
PRIMARY
DRUG BANK
DB06560
Created by admin on Mon Mar 31 20:32:40 GMT 2025 , Edited by admin on Mon Mar 31 20:32:40 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108119
Created by admin on Mon Mar 31 20:32:40 GMT 2025 , Edited by admin on Mon Mar 31 20:32:40 GMT 2025
PRIMARY
WIKIPEDIA
PASCOLIZUMAB
Created by admin on Mon Mar 31 20:32:40 GMT 2025 , Edited by admin on Mon Mar 31 20:32:40 GMT 2025
PRIMARY
CAS
331243-22-2
Created by admin on Mon Mar 31 20:32:40 GMT 2025 , Edited by admin on Mon Mar 31 20:32:40 GMT 2025
PRIMARY
NCI_THESAURUS
C88618
Created by admin on Mon Mar 31 20:32:40 GMT 2025 , Edited by admin on Mon Mar 31 20:32:40 GMT 2025
PRIMARY
FDA UNII
N1IOA09R6A
Created by admin on Mon Mar 31 20:32:40 GMT 2025 , Edited by admin on Mon Mar 31 20:32:40 GMT 2025
PRIMARY
ACTIVE MOIETY
PASCOLIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966